Jeff Pierson

Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with unmet needs and multi-billion-dollar markets. Its molecules have a rapid onset of action and offer innovative topical treatment opportunities by normalizing abnormal cough and lacrimation reflexes. Axalbion’s s strategy is to develop its lead compound AX-8 up-to Phase 2b to show clinical proof of concept across a representative patient population. It has already been tested in a Phase 2a trial with patients suffering from refractory chronic cough. Axalbion benefits from having proof of concept studies (clinical and non-clinical), strong safety and toxicology data, and the support of world’s leading experts and strategic partners. WE WELCOME PRIVATE INVESTORS AND VCs TO CONTACT US DIRECTLY FOR FURTHER DETAILS. contact@axalbion.com

Zorro Bio is creating a new standard in Personal Diagnostics and early disease detection. Founded by leading scientists Joe Gray and Bill Hyun, the company aims to improve health by rapidly delivering innovative at-home diagnostic tests directly to patients. Products under development target a wide range of diseases including influenza, COVID, tuberculosis, COPD, toxins exposure, cancers, cardiac markers, and multiple rare and fatal genetic conditions.

Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with unmet needs and multi-billion-dollar markets. Its molecules have a rapid onset of action and offer innovative topical treatment opportunities by normalizing abnormal cough and lacrimation reflexes. Axalbion’s s strategy is to develop its lead compound AX-8 up-to Phase 2b to show clinical proof of concept across a representative patient population. It has already been tested in a Phase 2a trial with patients suffering from refractory chronic cough. Axalbion benefits from having proof of concept studies (clinical and non-clinical), strong safety and toxicology data, and the support of world’s leading experts and strategic partners. WE WELCOME PRIVATE INVESTORS AND VCs TO CONTACT US DIRECTLY FOR FURTHER DETAILS. contact@axalbion.com

FreeDive AI is a personalized business training and education platform for scientists, technologists, engineers, and math experts who lack the requisite skills and career experience to become viable CEO candidates. Our mission is to train and educate thousands of professionals each year in entrepreneurial finance, accounting, data software, research & analytics, strategic thinking, and the lost art of effective business writing and communications.

CMBlu Energy develops and produces high-performance batteries for energy utility companies, grid operators as well as commercial and industrial demand. 🔋 Our Organic SolidFlow batteries use carbon-based molecules and are free from critical, flammable, or explosive materials, including lithium, making them: ✔️ safe, ✔️ scalable, ✔️ affordable, ✔️ recyclable, ✔️ and long-lasting. With the Organic SolidFlow battery, we deliver an extremely safe and sustainable key technology for the energy transition and a broad number of applications, including but not limited to: ☀️ Renewable power generation 🔌 EV charging infrastructure 🏭 Commercial & industrial energy demand ⚡️ Transmission and distribution 🏝 Micro- and off-grids ⛴ Maritime energy supply CMBlu is located in Alzenau, near Frankfurt/Main, and employes more than 240 people, 100 of whom scientists working in research and development. Together as a team, it’s our goal to enable reliable, safe, and long-lasting energy storage everywhere. 💡 For more information visit our website via www.cmblu.com and follow us here on LinkedIn and Twitter (@CMBlu_AG). Were hiring! 🚩 Visit our careers website for open vacancies and apply today: https://www.cmblu.com/en/careers/open-positions/ 💥 PS CMBlu Energy does NOT conduct interviews via Telegram. CMBlu Energy AG Industriestrasse 19 63755 Alzenau, Germany Commercial Register: HRB 12969 Registration court: Amtsgericht Aschaffenburg Represented by: Constantin Eis (CEO), Dr. Nastaran Krawczyk (CTO) Chairman, supervisory board: Dr. Peter Geigle Contact: Phone: +49 6023 9670100 E-mail: mail@cmblu.com VAT ID: DE297597992 (Sales tax identification number according to Sect. 27 a of the Sales Tax Law) Legal notice: https://www.cmblu.com/en/legal-notice/ Privacy policy: https://www.cmblu.com/en/privacy-policy/

Zorro Bio is creating a new standard in Personal Diagnostics and early disease detection. Founded by leading scientists Joe Gray and Bill Hyun, the company aims to improve health by rapidly delivering innovative at-home diagnostic tests directly to patients. Products under development target a wide range of diseases including influenza, COVID, tuberculosis, COPD, toxins exposure, cancers, cardiac markers, and multiple rare and fatal genetic conditions.